Earnings Feed
Start Free
Home/Filings/4/0001235802-09-000104
4//SEC Filing

CROWELL NANCY M 4

Accession 0001235802-09-000104

CIK 0000865231other
View on SEC.govCompany Profile

Filed

Oct 14, 8:00 PM ET

Accepted

Oct 15, 3:19 PM ET

Size

22.3 KB

Accession

0001235802-09-000104

Insider Transaction Report

Form 4
Period: 2009-10-14
CELL GENESYS INCCEGE
CROWELL NANCY M
Director
Transactions
  • Disposition to Issuer

    Stock Option (right to buy)

    2009-10-14−7,500→ 0 total
    Exercise: $5.02Exp: 2016-06-30→ Common Stock (7,500 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2009-10-14−7,500→ 0 total
    Exercise: $10.39Exp: 2014-06-30→ Common Stock (7,500 underlying)
  • Disposition to Issuer

    Common Stock

    2009-10-14−8,000→ 0 total
  • Disposition to Issuer

    Stock Option (right to buy)

    2009-10-14−7,500→ 0 total
    Exercise: $2.60Exp: 2018-06-30→ Common Stock (7,500 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2009-10-14−7,500→ 0 total
    Exercise: $8.81Exp: 2013-06-30→ Common Stock (7,500 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2009-10-14−7,500→ 0 total
    Exercise: $3.47Exp: 2017-06-30→ Common Stock (7,500 underlying)
  • Disposition to Issuer

    Stock Option (right to buy0

    2009-10-14−7,500→ 0 total
    Exercise: $5.35Exp: 2015-06-30→ Common Stock (7,500 underlying)
  • Disposition to Issuer

    Stock Option (right to buy0

    2009-10-14−7,500→ 0 total
    Exercise: $13.48Exp: 2012-06-28→ Common Stock (7,500 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2009-10-14−30,000→ 0 total
    Exercise: $24.63Exp: 2010-10-11→ Common Stock (30,000 underlying)
Footnotes (3)
  • [F1]Pursuant to the merger of Cell Genesys, Inc. with and into BioSante Pharmaceuticals, Inc. (the "Merger"), such shares were disposed of in exchange for 1,462 shares of BioSante common stock having a market value of $1.82 per share on the effective date of the Merger.
  • [F2]This option vested immediately on the day of grant.
  • [F3]This option was terminated for no consideration upon the effective time of the Merger.

Documents

1 file

Issuer

CELL GENESYS INC

CIK 0000865231

→
Entity typeother

Related Parties

1
  • filerCIK 0001210622

Filing Metadata

Form type
4
Filed
Oct 14, 8:00 PM ET
Accepted
Oct 15, 3:19 PM ET
Size
22.3 KB
View on SEC.gov